Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3048 per EA under NDC 31722016401. Its NADAC has been published 245 times since Oct 20, 2021.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

31722016401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213709

On Market Since

5/10/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 245 times since Oct 20, 2021, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3048 per EA
All-time high$0.3587 (Aug 16, 2023)
All-time low$0.2416 (Jul 17, 2024)
52-week high$0.3373
52-week low$0.3037
Median price$0.3124
Average price$0.3122
Largest weekly change-26.9% (Nov 20, 2024)
Weeks tracked245
Tracking sinceOct 20, 2021

Price History

1W

0.0%

1M

-0.3%

3M

-2.8%

6M

-2.4%

1Y

-9.6%

3Y

-6.1%

5Y

N/A

All

-12.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.3048 per EA (NDC 31722016401), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 12.9%. It has been tracked across 245 weekly CMS publications since Oct 20, 2021.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Oct 20, 2021, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.3587 (Aug 16, 2023), with a median of $0.3124 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DEXTROAMP-AMPHETAMIN 30 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 31722016401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.